A high-conviction short opportunity exists in Beyond Meat (BYND) due to fundamental business issues and expected selling pressure from debt holders, with a potential price target of $1. The entire quantum computing sector is viewed as a strong short, with specific stocks like Rigetti (RGTI), IonQ (IONQ), and Quantum Computing Inc. (QUBT) expected to decline significantly toward zero. For a long-term bullish play, consider Spruce Biosciences (SPRB), a biotech company with a promising drug that could lead to a 5x return upon potential FDA approval. These short ideas are a bet against fundamentally weak companies that have become popular with retail traders. Investors should be aware that shorting is inherently risky, and the biotech investment in SPRB requires a long-term holding period.

Beyond Meat (BYND)

• The speaker has a strong bearish (negative) view on Beyond Meat, calling it a "fake company mostly" with a negative gross margin.
• He believes the company will be out of business in a few years.
• He is actively shorting the stock, meaning he is betting that its price will fall. He mentioned his average short price was around $6 and that he was adding to his position.
• A key reason for his bearish view is a recent "cramdown," a financial event where debt holders forced the company to issue a large amount of new stock.
• He believes these debt holders, who received the stock for "free" as part of the deal, will be aggressively selling their shares, creating significant downward pressure on the stock price.
• He states, "I think it's going to one," indicating a price target of $1. He later says it will be "10 cents."
• He closed his position on one account after the stock dropped significantly during the stream but mentioned he might get back in if the price rallies.

Takeaways

• The speaker's sentiment on BYND is extremely bearish.
• The primary thesis is that the company has fundamental business problems (negative margins) and is facing immense selling pressure from bondholders who just received new shares.
• He sees the stock's recent price spike as a temporary event and a good opportunity to initiate a short position.
• Risk: The speaker notes that shorting is risky and that a stock can go up significantly before it goes down. He mentions a scenario where BYND could go to $100 in a short squeeze, which would cause large losses for short-sellers.

Quantum Computing Sector

• The speaker is extremely bearish on the entire quantum computing sector, stating, "I think quantum's dead."
• His view is reinforced by a comment from the Rigetti CEO, who allegedly said there is "no demand and no market for quantum computers."
• He believes all stocks in this sector are "going to zero" and that shorting them is "like shooting fish in a barrel."
• He performed a detailed analysis of a recent Google Quantum AI research paper, concluding that its claims of "practical quantum advantage" are overblown. He highlights peer reviews that called the paper "tedious," the results "not novel," and the claims of advantage contrived and unconvincing. This deep dive solidifies his belief that the technology is not commercially viable yet.

The following are specific quantum stocks he mentioned shorting:

• Rigetti Computing (RGTI): He is short "a lot of Rigetti" and believes the stock is going to $1.
• D-Wave Quantum (QBTS): This was a big loser for him previously, but he is now profiting from his short position. He mentioned having $40 puts on the stock in another account, which is a bet that the price will fall below $40.
• IonQ (IONQ): He is short the stock and noted it was his third-biggest winner for the year.
• Quantum Computing Inc. (QUBT): Referred to as BTQ in the transcript, he calls this his "favorite short" and says it is "dropping like a rock" and "going to zero."

Takeaways

• The core insight is a strong, sector-wide bearish call on quantum computing stocks.
• The thesis is based on a belief that there is currently no real market or demand for the product, a view he claims is shared by industry insiders.
• He is actively shorting multiple stocks in the sector (RGTI, QBTS, IONQ, QUBT) and sees it as a high-conviction trade.
• For investors, this suggests extreme caution is warranted for any long positions in the quantum computing space. The speaker believes these are not viable long-term investments at this time.

Spruce Biosciences (SPRB)

• The speaker holds a bullish (positive) view on SPRB.
• He describes it as a "rare disease drug company" and notes this is his area of expertise ("wheelhouse").
• The investment thesis is that the company has a drug that "works really well" and is likely to receive FDA approval, which will lead to significant sales.
• He believes the company is worth 5x its current trading price.
• He cautions that it is a biotech investment and "takes a while," meaning it is not an "instant win" and requires patience.

Takeaways

• SPRB is presented as a long-term, value-oriented investment based on fundamental analysis of its drug pipeline.
• This is a long (buy and hold) recommendation with a potential 5x return, but investors should be prepared for a longer holding period typical of biotech stocks awaiting regulatory approval.

"Meme Stocks" & Squeezes

• The speaker discusses several stocks popular with retail traders, often called "meme stocks," and expresses a consistently bearish view.
• He believes retail traders trying to engineer "short squeezes" in these names ultimately fail because the underlying companies are weak.
• Stocks mentioned that he successfully shorted against retail sentiment include:
  • Newegg (NEGG)
  • Kohl's (KSS)
  • OpenDoor (OPEN)
  • AMC Entertainment (AMC)

Takeaways

• The speaker's strategy is to bet against fundamentally weak companies that become popular with retail traders.
• He believes that in the long run, poor business fundamentals will cause the stock price to fall, regardless of short-term speculative frenzy.
• This serves as a cautionary tale against investing in companies solely based on social media hype or the hope of a short squeeze.

Intuitive Surgical (ISRG)

• The speaker mentioned ISRG in passing with a bullish sentiment.
• He contrasted it with the other speculative stocks he was discussing, calling it a "real company."
• He noted it was up 18% on the day.

Takeaways

• This mention highlights the speaker's preference for investing in or respecting companies with strong, proven business models, even if he isn't actively trading them.

Bitcoin (BTC)

• The speaker's sentiment on Bitcoin is neutral.
• When asked about it, he stated, "I don't have any conviction on Bitcoin."
• He suggests that for most people, holding cash is a reasonable alternative, as the interest income earned isn't significant enough to force them into other assets.

Takeaways

• No actionable insight is provided for BTC. The speaker is on the sidelines and does not have a strong opinion on its direction.

Private Market Investments

• The speaker mentions that his financial terminal, Godel, tracks the stock of privately held companies.
• He shows charts for several high-profile private companies, including:
  • SpaceX (SPAC): He notes the stock is up 50% year-to-date.
  • OpenAI
  • Anthropic
• He mentions they are working on features to allow users to trade these private company stocks.

Takeaways

• This highlights an emerging investment opportunity in the shares of large, late-stage private technology companies before they go public.
• While not a direct recommendation, it points to a growing market that sophisticated investors are watching.

Tesla (TSLA)

• The speaker's sentiment on Tesla is neutral.
• He notes that the company is reporting earnings and is "set for strong quarter," likely fueled by customers rushing to take advantage of expiring tax credits.
• He does not mention having a position or a strong personal conviction on the stock's direction.

Takeaways

• The commentary is purely informational, related to an upcoming earnings report. No specific investment thesis was offered.